Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Is the cholesterol-lowering effect of simvastatin influenced by CYP2D6 polymorphism?

× No keyword cloud information.

13 in total

1. Impact of CYP2D6 polymorphisms on the pharmacokinetics of lovastatin in Chinese subjects.

Authors: Ophelia Qi Ping Yin; Valiant Wah Lun Mak; Miao Hu; Benny Siu Pong Fok; Moses Sing Sum Chow; Brian Tomlinson
Journal: Eur J Clin Pharmacol Date: 2012-01-27 Impact factor: 2.953

Review 2. Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges.

Authors: Russell A Wilke; Debbie W Lin; Dan M Roden; Paul B Watkins; David Flockhart; Issam Zineh; Kathleen M Giacomini; Ronald M Krauss
Journal: Nat Rev Drug Discov Date: 2007-11 Impact factor: 84.694

Review 3. Pharmacogenetics of response to statins.

Authors: Issam Zineh
Journal: Curr Atheroscler Rep Date: 2007-09 Impact factor: 5.113

Review 4. HMG-CoA reductase inhibitors and myotoxicity.

Authors: M Ucar; T Mjörndal; R Dahlqvist
Journal: Drug Saf Date: 2000-06 Impact factor: 5.606

5. Ile118Val genetic polymorphism of CYP3A4 and its effects on lipid-lowering efficacy of simvastatin in Chinese hyperlipidemic patients.

Authors: An Wang; Bang-Ning Yu; Chen-Hui Luo; Zhi-Rong Tan; Gan Zhou; Lian-Sheng Wang; Wei Zhang; Zhi Li; Jie Liu; Hong-Hao Zhou
Journal: Eur J Clin Pharmacol Date: 2005-01-14 Impact factor: 2.953

Review 6. Pharmacokinetic-pharmacodynamic drug interactions with HMG-CoA reductase inhibitors.

Authors: David Williams; John Feely
Journal: Clin Pharmacokinet Date: 2002 Impact factor: 6.447

Review 7. How well tolerated are lipid-lowering drugs?

Authors: B Tomlinson; P Chan; W Lan
Journal: Drugs Aging Date: 2001 Impact factor: 3.923

Review 8. Individualized risk for statin-induced myopathy: current knowledge, emerging challenges and potential solutions.

Authors: QiPing Feng; Russell A Wilke; Tesfaye M Baye
Journal: Pharmacogenomics Date: 2012-04 Impact factor: 2.533

Review 9. Chemoprevention of breast cancer: implications for postmenopausal women.

Authors: Carol J Fabian; Bruce F Kimler
Journal: Drugs Aging Date: 2002 Impact factor: 3.923

10. The human hepatic metabolism of simvastatin hydroxy acid is mediated primarily by CYP3A, and not CYP2D6.

Authors: Thomayant Prueksaritanont; Bennett Ma; Nathan Yu
Journal: Br J Clin Pharmacol Date: 2003-07 Impact factor: 4.335